DiscoverBioTalk UnzippedBiotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle
Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle

Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle

Update: 2024-10-21
Share

Description

EP-23. In the second half of this compelling conversation on BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their deep dive with Scott Ogle, CEO of TruLab. They explore the surprising parallels between the banking and pharma industries, the game-changing role of digital twinning in clinical trials, and the biotech funding landscape. Scott also shares his thoughts on leadership, mentorship, and the impact of the Inflation Reduction Act on pharma innovation. This episode offers listeners valuable insights into the future of drug development and the challenges of balancing professional and personal life in a fast-paced industry.




Chapters


1:09 - Comparison of the Banking Industry to the Pharma Industry


5:18 - Data Integrity, Same For Decentralized Trials?


8:33 - Biotech Funding Trends


11:18 - NEW NEWS! – Digital Twinning in Clinical Trials


16:15 - What Advice Would You Give to Your Younger Self?


20:57 - Mentorship and Its Impact, How it Shaped Scott


23:45 - Balancing Work and Personal Life


24:32 - The Inflation Reduction Act and Innovation




Takeaways



  • The regulatory environment in pharma can slow down innovation.



  • Digital twinning in clinical trials could revolutionize drug development.



  • Family influences play a significant role in shaping business perspectives.



  • The need for a strong company culture to maintain values during growth.



  • Biotech funding trends are influenced by macroeconomic factors like interest rates.



  • The importance of mentorship in professional development.






Sound Bites



  • “The similarities between the banking industry and the pharma industry is eerily similar.”



  • “Quality is really what we do.”



  • “Being quality is core to software.”



  • “It’s really clear people care more about their money than they do their healthcare.”



  • “Biotech and large pharma seem to balance each other out.”



  • “The career for you is at the intersection of what you are good at and what you like to do.” 



  • “If you’re good at something and you like to do it, it fuels your energy to keep getting better.”



  • “Enjoy the impact in what you’re doing and accomplishing!”




New News Story: 



 


How to reach us:


Scott Ogle


https://www.linkedin.com/in/scott-ogle/ 


TruLab - https://trulab.com/ 


 


Dr. Chad Briscoe


https://www.linkedin.com/in/chadbriscoe/ 


Celerion - https://www.celerion.com/  


Gregory Austin


https://www.linkedin.com/in/gregoryaustin1/ 


ECI - https://eci-rx.com


Image Credits


Digital Twinning - Credit Getty Images


Simulation - Credit: andrush / Adobe Stock


Tomáš Helikar - https://www.linkedin.com/in/tomashelikar/ 


Nebraska Swan computer - https://newsroom.unl.edu/announce/cse/16380/90600


Brian Hamilton - https://inmatestoentrepreneurs.org/board/brian-hamilton/ 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle

Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle

BioTalk Unzipped